Correctional Management of HIV and HCV in the COVID-19 Era * Free Webinar - Sponsored by Merck
Previously recorded during the 2020 Virtual Spring Conference on Correctional Health Care
Correctional facilities have historically registered exceptionally high infectious diseases rates. HIV prevalence is generally 5 to 7 times higher than in the surrounding community, and HCV can be 10 to 13 times greater. This year, the novel coronavirus SARS-CoV-2 has ripped through U.S. correctional populations. Despite efforts to shrink censuses, rates often are 10 times greater compared to the community. The speaker will review issues related to HIV and HCV management in correctional facilities, and how this new epidemic affects discharge planning.
1. Review how past epidemics of infectious diseases (HIV, HCV and TB) could have led to the prediction that COVID-19 would hit corrections especially hard
2. Discuss how the advent of COVID can affect management of HIV and HCV inside and outside of jails and prisons
3. Compare correctional testing strategies for HIV and HCV and those for the new coronavirus
About the presenter
Dr. Spaulding obtained her M.D. from the Medical College of Virginia and her M.P.H. through John Hopkins. She trained in internal medicine and infectious disease. For the past 22 years, she has focused on correctional health and has authored 100 publications. She served as medical director for the RI Department of Corrections, a combined jail/prison for 6 years. Since 2005 she has been on faculty at Emory’s Rollins School of Public Health, where she is currently an Associate Professor of Epidemiology.
This Free Webinar:
Includes access to the webinar recording and CE credit - 1.0 hours for ACCME, ADA, ANCC, APA and CCHP. If you would like a copy of the presentation and info on how to claim CE credit, please send an email to email@example.com.